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Multiple excitatory and inhibitory interneurons form
the motor circuit with motor neurons in the ventral
spinal cord. Notch signaling initiates the diversifica-
tion of immature V2-interneurons into excitatory
V2a-interneurons and inhibitory V2b-interneurons.
Here, we provide a transcriptional regulatory mecha-
nism underlying their balanced production. LIM-only
protein LMO4 controls this binary cell fate choice by
regulating the activity of V2a- and V2b-specific LIM
complexes inversely. In the spinal cord, LMO4
induces GABAergic V2b-interneurons in collabora-
tionwith SCLand inhibits Lhx3 fromgenerating gluta-
matergic V2a-interneuons. In LMO4;SCL compound
mutant embryos, V2a-interneurons increase mark-
edly at the expense of V2b-interneurons. We further
demonstrate that LMO4 nucleates the assembly of
a novel LIM-complex containing SCL, Gata2, and
NLI. This complex activates specific enhancers in
V2b-genes consisting of binding sites for SCL and
Gata2, therebypromotingV2b-interneuron fate.Thus,
LMO4 plays essential roles in directing a balanced
generation of inhibitory and excitatory neurons in the
ventral spinal cord.
INTRODUCTION
A proportional production of excitatory and inhibitory neuronal
subtypes is important, as the balance between these two
opposing activities is critical to establish functional neuronal
circuits. In the ventral spinal cord, interneurons and motor
neurons form a neural circuit that coordinates locomotion. Four
classes of ventral interneurons, V0, V1, V2, and V3, emerge from
progenitors in distinct progenitor domains, termed p0, p1, p2,
and p3, respectively (Jessell, 2000). These interneurons acquire
characteristics of either excitatory neurons that use glutamate
as neurotransmitters or inhibitory neurons that utilize GABA
(gamma-aminobutyrate) and/or glycine (Lanuza et al., 2004;
Alvarez et al., 2005; Kimura et al., 2006). However, mechanisms
that govern the alternative fate choices between excitatory and
inhibitoryneurons in theventral spinal cordarepoorly understood.The p2 progenitor cells produce immature V2-interneruons
(V2-INs) that express combinations of transcription factors;
LIM homeodomain (LIM-HD) factor Lhx3, zinc finger protein
Gata2, basic helix-loop-helix (bHLH) factor Mash1 and forkhead
protein FoxN4 (Del Barrio et al., 2007; Karunaratne et al., 2002;
Li et al., 2005; Parras et al., 2002; Thaler et al., 2002; Zhou
et al., 2000). These cells diversify into two distinct cell types,
V2a-INs and V2b-INs. While V2a and V2b-INs share several
properties such as dorsoventral position and ipsilateral axonal
projection, they differ in the expression of marker genes and
the choice of neurotransmitters. Notch-Delta interactions initiate
this binary cell fate choice in immature V2-INs (Figure 1A;
Del Barrio et al., 2007; Peng et al., 2007; Yang et al., 2006).
Delta4+ signal-sending V2a-INsmaintain Lhx3while suppressing
Gata2, whereas Notch1+ signal-receiving V2b-INs upregulate
a bHLH factor SCL (also known as Tal1) and Gata2 while
silencing Lhx3. V2a-INs mature to become Lhx3+Chx10+ excit-
atory neurons, whereas V2b-INs develop into inhibitory neurons
labeled by Gata2/3 and SCL (Kimura et al., 2006; Lundfald et al.,
2007; Peng et al., 2007). Thus, cell-cell interactions through
Delta4 and Notch1 set up distinct transcription factor profiles
in V2a and V2b cells, thereby generating two distinct V2-IN
subtypes from a pool of genetically homogenous p2 progenitors.
Forced expression of Gata2 in the dorsal spinal cord triggers
Gata3+ V2b-INs, while suppressing the development of other
interneurons, including V2a-INs (Karunaratne et al., 2002).
Gata2 null mutants are deficient in V2a-INs as monitored by
Chx10 expression (Zhou et al., 2000) but remain undetermined
for V2b-INs. Expression of SCL also induces ectopic formation
of Gata2/Gata3+ V2b-INs in the neural tube and simultaneously
suppresses Chx10+ V2a-IN formation (Muroyama et al., 2005).
Conversely, deletion of SCL gene in the spinal cord leads to
downregulation of Gata2 and loss of Gata3+ V2b-INs, accompa-
nied by increased V2a-INs (Muroyama et al., 2005). These results
indicate that Gata2 and SCL are capable of directing transcrip-
tion pathways to specify V2b-INs, bypassing the initial diversifi-
cation step by Notch-Delta signaling, and that V2 cells remain
plastic between V2a and V2b fates even after adopting cell iden-
tities via Notch-Delta signaling. A majority of Chx10+ V2a-INs
are glutamatergic, whereas GATA3+ V2b-INs become mainly
GABAergic although a small fraction of V2b-derived cells display
a glycinergic phenotype (Al-Mosawie et al., 2007; Batista et al.,
2008; Kimura et al., 2006; Lundfald et al., 2007). Consistently,
ablation of Chx10+ V2a-INs results in a substantial reduction ofNeuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc. 839
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LMO4 as a Balancer in a Binary Cell Fate DecisionFigure 1. LMO4 Suppresses Formation of Glutamatergic V2a-INs and Cooperates with SCL to Promote GABAergic V2b-IN Generation
(A) A schematic model shows the diversification process of p2 progenitors to V2a-INs or V2b-INs.
(B–E) In situ hybridization for Vglut2 and immunostaining with Chx10 antibody in chicks electroporated (+ side) with Lhx3 alone or Lhx3 plus LMO4. Ectopic
Chx10+Vglut2+ V2a-INs in the dorsal spinal cord are marked by brackets.
(F–Q) Cell differentiation analyses on chick embryos electroporatedwith constructs listed on left, using immunostainingwithGata3 or Chx10 antibodies and in situ
hybridization for Gad1 or Vglut2. Brackets mark ectopic Gata3+Gad1+ V2b-INs on the electroporated side (+).
(R and S) The effect on V2a-IN and V2b-IN formation was quantified by the ratio of Gata3+ or Chx10+ cells on the electroporated side (+) over the control side ().
The error bars represent the standard deviation.ventral glutamatergic neurons (Crone et al., 2008). Key ques-
tions, however, remain to be answered: first, what is the mecha-
nism that segregates V2a and V2b fate after the initial binary cell
identity selection by Notch-Delta signaling; and second, how are
immature V2-INs transcriptionally directed to either glutamater-
gic or GABAergic cell fates.
The nuclear LIM proteins are composed of LIM-HD transcrip-
tion factors and LIM-only proteins (LMOs; Hobert and Westphal,
2000). LIM-HD factors, which contain LIM domains for protein-
protein interactions and the DNA-binding homeodomain, play840 Neuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc.important roles in establishing neuronal subtype identities in
the CNS (Lee and Pfaff, 2001). Structural and in vivo functional
studies in vertebrates and invertebrates have revealed that
LIM-HD factors form multiprotein complexes with a cofactor
NLI (Ldb, CLIM, Chip), which consists of a LIM domain interac-
tion region (NLI-LID) and a self dimerization domain (NLI-DD;
Jurata et al., 1998; Thaler et al., 2002; van Meyel et al., 1999).
These NLI-based LIM-complexes vary considerably in their
components and organization depending on cell types, leading
to cell context-specific gene expression. Lhx3 specifies V2a-IN
Neuron
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noted as V2-tetramer) that regulates V2a-IN genes by binding
the V2-tetramer-specific response elements (Thaler et al.,
2002; Lee et al., 2008). Mice deficient in Lhx3 (and its redundant
factor Lhx4) are impaired in V2a-IN formation, whereas misex-
pression of Lhx3 induces ectopic Chx10+ V2a-INs in the dorsal
spinal cord (Lee and Pfaff, 2001; Sharma et al., 1998; Tanabe
et al., 1998; Thaler et al., 2002). The role of Lhx3 in establishing
neurotransmitter characteristics of V2a-INs remains to be deter-
mined. Unlike LIM-HD proteins, LMOproteins have LIM domains
but lack any functional DNA-bindingmotif. Among the four verte-
brate LMO genes, LMO4 has been shown to suppress the
V2a-IN differentiation pathway by inhibiting the assembly of
the V2-tetramer by competing with Lhx3 for binding NLI (Lee
et al., 2008). As LIM-HD factors are not expressed in V2b-INs,
V2b-specification is unlikely directed by a conventional LIM-
complex containing LIM-HD proteins and NLI. Interestingly,
however, the identification of the hematopoietic complex con-
taining NLI, LMO2, SCL, and Gata1 (Wadman et al., 1997), along
with aforementioned roles of SCL and Gata2 in V2b-IN forma-
tion, raises the possibility that a similar complex may be involved
in V2b-IN specification.
In this report, we set out to understand the mechanistic basis
of the balance between excitatory V2a-INs and inhibitory
V2b-INs that is initially set up by Notch-Delta signaling. Our
results reveal an essential function for LMO4 in directing a
balanced generation of V2a- and V2b-INs in the ventral spinal
cord. While suppressing glutamatergic V2a fate by inhibiting the
formation of the V2-tetramer, LMO4 simultaneously promotes
GABAergic V2b-IN identity by assembling a LIM complex with
SCL, Gata2, and NLI. The opposite action of LMO4 in two
distinct LIM-complexes directing V2a-IN and V2b-IN fates
provides a novelmolecularmechanismbywhich a transcriptional
modulator such as LMO4 contributes to striking a balance
between two parallel developmental pathways following the
initial alternate cell fate determination.
RESULTS
LMO4 Inhibits Glutamatergic Differentiation by Lhx3
We tested whether Lhx3 is capable of promoting a glutamatergic
cell fate in the developing chick spinal cord. Ectopic expression
of Lhx3 using electroporation induced the glutamatergic
neuronal marker, vesicular glutamate transporter 2 (Vglut2),
concomitant with the upregulation of Chx10, in the dorsal neural
tube (parenthesis in Figures 1B and 1C). Interestingly, coelectro-
poration of LMO4 with Lhx3 suppressed the glutamatergic
neuronal differentiation by Lhx3 (Figures 1D and 1E), consistent
with the previous report that LMO4 antagonizes the formation of
the V2-tetramer complex that contains Lhx3 (Lee et al., 2008).
These findings suggest that Lhx3 is sufficient to induce glutama-
tergic cell fates in the neural tube and LMO4 is an efficient
blocker of glutamatergic differentiation by Lhx3.
LMO4 Cooperates with SCL to Reciprocally Regulate
Development of V2a- and V2b-INs
At E11.5, LMO4, Gata2, and SCL are expressed in overlapping
areas in the ventricular zone where V2b-INs are being specified(see Figures S1A and S1B available online). To investigate the
possible function of LMO4 in GABAergic V2b-IN development,
wemisexpressed LMO4, in combinationwith the V2b-IN-specific
factor SCL, using in ovo electroporation of chick embryos. As
reported (Muroyama et al., 2005), misexpressed SCL led to the
ectopic formation of Gata3+ V2b-INs, resulting in four times
more Gata3+ V2b-INs in the electroporated side compared to
the control side (Figures 1F and 1R). Interestingly, while LMO4
did not induce the formation of V2b-INs, coexpression of
LMO4 along with SCL dramatically increased the number of
V2b-INs to 8-fold (Figures 1J, 1N, and 1R). To determine whether
SCL regulates theGABAergic cell fate, wemonitored the expres-
sion of the Gad1 gene encoding glutamic acid decarboxylase
that synthesizes GABA. SCL inducedGad1 expressionmodestly
(Figure 1G). Coexpression of LMO4with SCL resulted in a robust
upregulation of Gad1 throughout dorsoventral spinal cord
(parenthesis in Figure 1K), whereas LMO4 alone is not sufficient
for triggering Gad1 expression (Figure 1O). These results
suggest that LMO4 promotes the activity of SCL in generating
GABAergic V2b-INs.
These results led us to test whether LMO4 also facilitates the
ability of SCL to antagonize V2a-IN differentiation (Muroyama
et al., 2005). While forced expression of SCL reduced Chx10+
endogenous V2a-INs to 65%of the control side, the combination
of SCL and LMO4 further suppressed V2a-IN formation to 44%
(Figures 1H, 1L, 1P, and 1S). Similarly, SCL suppressed Vglut2
expression, which was markedly exacerbated by coexpression
of LMO4, leaving only a small number of glutamatergic neurons
in the electroporated side (Figures 1I, 1M, and 1Q). These results
indicate that LMO4 cooperates with SCL in inhibiting glutamater-
gic V2a-IN differentiation.
To understand the functional basis underlying the cooperativ-
ity of SCL and LMO4, we employed SCL-F238G bearing a point
mutation in helix2 of the bHLH domain. This mutant is unable to
transcriptionally synergize with LMO2 in mammalian cells and
ineffective in triggering ectopic V2b-IN generation (Muroyama
et al., 2005; Schlaeger et al., 2004). SCL-F238G did not coop-
erate with LMO4 either in induction of V2b-INs or in suppression
of V2a-INs (Figures S1C, 1R, and 1S), suggesting that the tran-
scriptional synergy between SCL and LMO4 is necessary for
their cooperative action in promoting V2b-fate and blocking
V2a-differentiation.
These results demonstrate that LMO4 plays opposing roles in
the determination of excitatory V2a and inhibitory V2b fates.
LMO4 functionally collaborates with SCL in promoting
GABAergic V2b-IN fate and inhibiting glutamatergic V2a-IN
differentiation.
LMO4 and SCL Are Required for GABAergic
V2b-IN Generation
To further define the role of LMO4 in V2b-IN development,
we investigated LMO4 mutant and LMO4;SCL compound
mutant embryos (Elefanty et al., 1998; Lee et al., 2005a). Due to
the early embryonic lethality of SCL null mutants (Porcher et al.,
1996), we analyzed LMO4-heterozygote and LMO4 null muta-
tions in a SCL-heterozygous background. We used a previously
reported SCL-LacZ allele, which deletes all SCL coding
sequences, in our analyses (Elefanty et al., 1998). First, weNeuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc. 841
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mRNA, a V2b-IN-specific marker, from dissected spinal cords
using quantitative RT-PCR (qRT-PCR). The level of Gata3
mRNA relative to the internal control cyclophilin was highest in
the wild-type and progressively decreased to 50% in LMO4+/
and 17% in LMO4/ embryos at E14.5 (Figure 2A). In contrast
to the marked downregulation of Gata3, the expression of
Gata2 and SCL did not significantly reduce in LMO4/ embryos
(Figure S2). The reduction of Gata3 expression was further
augmented by the loss of one allele of SCL gene, resulting in
11% in LMO4+/;SCL+/ and only 5% in LMO4/;SCL+/
embryos (Figure 2A), consistent with the cooperative action
between LMO4 and SCL in the chick spinal cord. Second, to
determine whether the loss of LMO4 and/or SCL affects the
inhibitory neuronal phenotypes of V2b-INs, we examined
GABAergic and glycinergic neurons in the ventral spinal cord
of LMO4 and SCL mutants at E13.5 using immunostaining with
anti-Glycine and anti-GABA antibodies. While the small number
of Glycine+ cells in the ventral spinal cord did not vary among
wild-type and mutant embryos (data not shown), the number of
GABA+ cells within the ventral spinal cord of LMO4 and SCL
mutants was observed to change in comparison to wild-type
animals. LMO4+/;SCL+/ embryos exhibited a 26% decrease
in GABA+ cells, whereas neither LMO4+/ nor SCL+/ showed
any observable change in GABA+ ventral interneurons (Figures
2B and 2C). Given the specific expression of SCL in V2b-INs
(Muroyama et al., 2005; Smith et al., 2002), the change in
GABA+ ventral interneurons in LMO4+/;SCL+/ embryos likely
reflects a defective acquisition of appropriate neurotransmitter
profiles by the V2b-INs. Similarly to Gata3 expression, the
greatest reduction in GABA+ ventral interneurons was seen in
LMO4/;SCL+/ embryos to 46% of wild-type controls (Figures
2A and 2B), indicating that the loss of LMO4 and SCL genes
Figure 2. Suppression of Gata3+ GABAergic
V2b-INs and Increase in Chx10+ V2a-INs
in LMO4 and SCL Mutant Embryos
(A) qRT-PCR to monitor Gata3 mRNA levels in
E14.5 littermate embryos.
(B) Quantification of GABA+ and Chx10+ cells in
E13.5 embryos by the percentage of Chx10+ or
GABA+ cells in each embryo over the wild-type
littermate control. * indicates significant differ-
ences for both Chx10 and GABA, and ** indicates
a significant difference for Chx10. * and **p < 0.001
in the two-tailed t test.
(C) Immunohistochemical analyses with Chx10
and GABA antibodies in E13.5 littermate embryos
at thoracic spinal cord. The ventral quadrant spinal
cord is outlined.
The error bars represent the standard deviation
(A and B).
leads to a progressive loss of ventral
GABAergic interneurons. Considering
the dramatic downregulation of Gata3 in
LMO4/;SCL+/ embryos (Figure 2A)
and the presence of multiple types of
GABAergic interneurons in the ventral
spinal cord in addition to V2b-INs (Lanuza et al., 2004; Alvarez
et al., 2005; Kimura et al., 2006), it is likely that the majority of
remaining GABAergic interneurons in LMO4/;SCL+/ mutants
are non-V2b-INs. These results establish that LMO4 and SCL
cooperate to specify the GABAergic fate in V2b-INs. Lastly, we
examined the production of V2a-INs in mutant embryos of
various genotypes using immunostaining with anti-Chx10
antibody. Chx10+ V2a-INs were significantly increased in
LMO4 null embryos to 134% of wild-type at E13.5 (Figures
2B and 2C). Interestingly, LMO4+/;SCL+/ embryos displayed
increased V2a-IN generation to 157% of wild-type control
littermate, although neither LMO4+/ nor SCL+/ showed any
significant change in the number of V2a-INs (Figures 2B and
2C), indicating a genetic interaction between LMO4 and SCL.
In LMO4/;SCL+/ embryos, glutamatergic Chx10+ V2a-INs
were further increased to 193% of wild-type control (Figures
2B, 2C, and S3). Combined with the loss of Gata3+GABA+
V2b-INs, these results suggest that the prospective Gata3+
GABA+ V2b-INs changed their fate to glutamatergic Chx10+
V2a-INs in LMO4;SCL mutants. Together, these data establish
that LMO4 is required to enhance GABAergic V2b-differentiation
and suppress glutamatergic V2a-fate, playing an important role
in maintaining a balance between V2a-INs and V2b-INs, in part
by collaborating with SCL.
LMO4 Nucleates the Assembly of a Multiprotein
Complex Including SCL and Gata2
To understand the molecular basis of the cooperative action
between LMO4 and SCL in promoting V2b fate, we considered
the possibility that LMO4 mediates the formation of a higher-
order LIM complex with SCL, Gata2, and NLI during V2b-IN
development. To test this idea, we assessed interactions among
LMO4, SCL, Gata2, and NLI in yeast two-hybrid and GST-pull842 Neuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc.
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LMO4 as a Balancer in a Binary Cell Fate DecisionFigure 3. Formation of a High-Order LIM
Complex Mediated by LMO4 and NLI
(A) Protein-protein interactions monitored by
the yeast two hybrid assays.  represents no
interaction and + shows the interaction intensity
determined by the color intensity on the X-gal
containing plates. ND, not determined.
(B–D) In vitro GST-pull down assays using in vitro
translated, 35S-labeled proteins and bacterially
purified GST-fusion proteins.
(E) LMO4 associates with SCL and Gata2 in cells,
as assessed by coIP assays in HEK293 cells trans-
fected with SCL, Gata2, and Flag-tagged LMO4.
(F) In vivo GST-pull down assays in HEK293 cells
expressing LMO4, NLI, and HA-SCL or HA-SCL-
F238G (FG), along with GST-NLI or GST-Gata2.
NLI- or Gata2-bound proteins were purified with
glutathione Sepharose beads and probed with
HA-antibody.
(G) The proposed model for the V2b complex
consisting of 2NLI:2Gata2:2LMO4:2SCL-E47.down assays. LMO4 interacts with not only a well-known
LIM-interactor NLI but also Gata2 and SCL, whereas SCL binds
neither Gata2 nor NLI (Figures 3A–3D). NLI interacts with Gata2
as well as LMO4 and NLI (Figures 3A–3C). The interaction of
LMO4 with SCL, Gata2 and NLI prompted us to test whether
LMO4 enables SCL to be indirectly tethered to Gata2 and/or
NLI. In support of this idea, GST pull-down assays revealed
that LMO4 bridges SCL to Gata2 and NLI (Figures 3C and 3D).
Moreover, the addition of NLI strengthened the LMO4-mediated
association between Gata2 and SCL (Figure 3D), raising the
possibility that all four proteins assemble into a multiprotein
complex. Tomap the Gata2-interaction domain in NLI, we tested
the binding of Gata2 to either NLI-DD, which contains the
dimerization domain (DD) of NLI, or NLI-LID consisting of the
LIM-interaction domain (LID) of NLI (Figure S4; Thaler et al.,
2002). Gata2 preferentially bound NLI-DD in GST-pull down
and yeast two hybrid tests, whereas LMO4 interacted with
NLI-LID (Figure 3B; data not shown), suggesting that NLI:Gata2
and NLI:LMO4 interactions could occur simultaneously allowing
the multi-protein complex to form. The binding between Gata2
and NLI was also strengthened by the addition of LMO4
(Figure 3C), further supporting the high-order complex model.
Consistent with this in vitro interaction profile, coimmunoprecipi-
tation assays in HEK293 cells revealed that LMO4 associates
with SCL and Gata2 in cells (Figure 3E). Together, our results
suggest that LMO4 and NLI play critical roles for nucleating
the multi-protein complex of NLI:Gata2:LMO4:SCL and that
two of these units could be assembled into a higher-order
LIM-complex of 2NLI:2Gata2:2LMO4:2SCL through NLI-dimer-
ization (Figure 3G).
While SCL can transcriptionally synergize with LMO2 and
induce hematopoietic differentiation of embryonic stem cells,
SCL-F238G is inert (Muroyama et al., 2005; Schlaeger et al.,
2004). SCL-F238G is also inactive in V2b specification in the
developing spinal cord and does not cooperate with LMO4 forV2b-IN differentiation (Figures 1R and S1C). Thus, under-
standing the mechanism of the functional deficiency of
SCL-F238G is likely to provide crucial insights into the coopera-
tion of SCL and LMO4 in V2b-IN specification. In yeast two-
hybrid assays, both SCL and SCL-F238G heterodimerized with
E47 effectively (Figure 3A). Contrary to the expectation that
SCL-F238G would be unable to bind LMOs, SCL-F238G inter-
acted with LMO1, LMO2, and LMO4 as strongly as wild-type
SCL (Figure 3A; data not shown), suggesting that SCL-F238G
is intact in an one-to-one interaction with LMOs. Next, we inves-
tigated whether SCL-F238G is incorporated into the complex of
NLI:Gata2:LMO4:SCL in cells using in vivo GST pull-down
assays. GST-NLI and LMO4 were expressed along with either
SCL or SCL-F238G in HEK293 cells and NLI-associated proteins
were purified with glutathione Sepharose beads. Consistent with
the in vitro results, NLI associated with SCL, presumably through
a bridging molecule LMO4 (Figure 3F). Interestingly, NLI failed to
copurify SCL-F238G under the same condition (Figure 3F),
suggesting that SCL-F238G is incapable of forming a complex
with NLI. We also investigated the LMO4-mediated association
between Gata2 and SCL in cells. GST-Gata2 associated with
SCL, but not with SCL-F238G (Figure 3F). Thus, SCL-F238G,
which is defective in V2b-IN induction, is incapable of forming
a complex with NLI, Gata2, and LMO4 in cells. These data
strongly suggest that formation of a complex containing SCL,
NLI, Gata2, and LMO4 in cells is needed for V2b-IN induction.
Dimerization of NLI Is Required
for V2b-IN Differentiation
Using the N-terminal self-dimerization and C-terminal LIM-inter-
action domains (NLI-DD and NLI-LID), NLI mediates the forma-
tion of two LIM complexes that induce the specification of motor
neurons and V2a-INs (Lee and Pfaff, 2003; Thaler et al., 2002). As
NLI is highly upregulated in differentiating neurons in the devel-
oping spinal cord (Thaler et al., 2002), we predicted thatNeuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc. 843
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into a higher-order LIM complex that we named the V2b complex
(Figure 3G) and that the V2b complex is responsible for directing
V2b-IN specification. To test this hypothesis, we used a domi-
nant-negative NLI-DD, which blocks the dimerization of endog-
enous NLI (Figure S4; Thaler et al., 2002). NLI-DD effectively
inhibited V2b-IN specification triggered by SCL expression in
the chick neural tube (Figures 4A and 4B). These results establish
that the dimerization of NLI is required for SCL to induce ectopic
V2b-IN generation and support our V2b complex model.
The Transcriptional Synergy among Components
of the V2b Complex and SSDP1
Our data establish the biochemical basis underlying the
assembly of the V2b complex and its critical role in V2b-IN differ-
entiation. However, the transcriptional regulatory mechanism by
which the components of the V2b complex cooperate with each
other to specify V2b-INs remains unclear. It is possible that the
Figure 4. NLI Dimerization Is Required
for SCL-Induced V2b-IN Formation
(A) Immunostaining analyses in chicks electropo-
rated with HA-SCL along with either LacZ or
NLI-DD.
(B) The efficiency of V2b-IN induction was
quantified by the ratio of Gata3+ V2b-INs on the
electroporated side (+) over the control side ().
The error bars represent the standard deviation.
Figure 5. The Recruitment of SSDP1 to
the V2b Complex Leads to Transcriptional
Synergy
(A) CoIP assays in HEK293 cells transfected with
HA-LMO4, Flag-SSDP1 and NLI. * shows the
heavy chain bands.
(B–D) Luciferase reporter assays in HEK293 cells.
UAS:LUC with Gal4-SCL (B) or Gal4-Gata2 (C) or
E-box-GATA:LUC (D) were used as reporters.
The error bars represent the standard deviation.
formation of the V2b complex results in
transcriptional synergy by facilitating
recruitment of coactivators. This could
involve new coactivator-interacting inter-
faces resulting from formation of the complex and/or a combined
action of multiple interaction interfaces provided by individual
subunits of the complex. Interestingly, single-stranded DNA-
binding proteins (SSDPs) have been found as NLI-interacting
proteins (Chen et al., 2002; vanMeyel et al., 2003) and to function
as coactivators for the hematopoietic complex consisting of
SCL, Gata1, LMO2, and NLI (Xu et al., 2007). Thus, NLI (and
possibly other subunits of the V2b complex) may recruit SSDPs
to the V2b complex, which subsequently enhances the tran-
scriptional activating potential of the V2b complex and thus
promotes V2b-IN specification. To test this possibility, we first
tested whether LMO4 associates with SSDP1, which is abun-
dantly expressed in spinal neurons (unpublished data). HA-
LMO4 and Flag-SSDP1 were expressed without or with NLI in
HEK293 cells and the complex containing SSDP1 was immuno-
purified with Flag antibody. Interestingly, overexpressed NLI
stabilized LMO4 protein (Figure 5A), suggesting that formation
of a complex between LMO4 and NLI increases the stability of844 Neuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc.
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sion of dLMO protein requires Chip, a NLI ortholog, during
Drosophila wing development (Milan and Cohen, 2000). SSDP1
efficiently immunoprecipitated LMO4 as well as its known inter-
actor NLI in coimmunoprecipitation assays (coIP; Figure 5A).
These results suggest that NLI and LMO4 are capable of recruit-
ing SSDP1 to the V2b complex.
Next, we tested whether LMO4, NLI, and SSDP1 potentiate
the transcriptional activity of SCL orGata2 using cell-based lucif-
erase reporter assays. SCL and GATA2 are mild transcriptional
activators when their transcriptional activity was measured as
Gal4-DNA binding domain (Gal4-DBD) fusions in Gal4-binding
UAS:Luciferase reporter (Figures 5B and 5C). Interestingly, co-
expression of LMO4, NLI, and SSDP1 led to a strongly syner-
gistic stimulation of the SCL- or Gata2-mediated transcription,
while expression of LMO4, NLI, or SSDP1 alonewas not effective
(Figures 5B and 5C; data not shown). These results suggest that
recruitment of SSDP1 to SCL or Gata2 through NLI and LMO4
augments the transcriptional activity of SCL and Gata2. Next,
we wanted to monitor the transcriptional activity of the V2b
complex that contains both DNA-binding components SCL
and Gata2. To this end, we utilized an E-box-GATA composite
element, which was identified as a binding site of the hematopoi-
etic complex containing Gata1, SCL, NLI, and LMO2 (Wadman
et al., 1997). This is a bipartite DNA response element composed
of a bHLH-binding E-box and a Gata protein-binding GATA-site
separated by nine base pairs. We measured the transcriptional
activation of a luciferase reporter linked to multimerized E-box-
GATA elements, upon expression of SCL, Gata2, LMO4, NLI,
and SSDP1, alone and in combinations. Remarkably, coexpres-
sion of the V2b complex components along with SSDP1 led to
a strongly synergistic activation of this reporter (Figure 5D).
Together, these data indicate that the V2b complex recognizes
and transactivates E-box-GATA composite elements and
demonstrate that the formation of the V2b complex results in
transcriptional synergy at least in part by recruiting the coactiva-
tor SSDP1.
Identification of Enhancers in Gata2 and Gata3 Genes
Responsive to the V2b Complex
To characterize the in vivo function of the V2b complex in
transcriptional regulation during spinal cord development, we
sought the physiological target genes of the V2b complex.
Based on the architecture of the V2b complex (Figure 3G), we
reasoned that the V2b complex-response elements would
consist of at least two reiterated GATA-E-box composite
elements and have a capacity to direct gene expression to
V2b-INs, in which the endogenous V2b complex is expected to
be assembled. Notably, the screen for binding elements of the
SCL/Gata1-containing hematopoietic complex isolated not
only the consensus E-box sequences (CAnnTG) and GATA site
(GATA) but also noncanonical forms of the E-box motif
(CAnnnTG) and GATA site (GATT; Wadman et al., 1997). Thus,
we also considered the possibility that the V2b complex-
response elements consist of canonical and/or noncanonical
E-boxes and GATA sites. A 190 bp enhancer region in intron 5
of Gata2 has previously been shown to be sufficient for directing
the reporter gene expression to V2-INs in transgenic mouseembryos (Zhou et al., 2000). However, the specific DNA
sequences critical for this V2-specific enhancer activity remain
unclear. Intriguingly, we noted that a pair of bipartite DNA
sequences consisting of noncanonical E-boxes (CAnnnTG) and
GATA sites is present in this enhancer region (Figure 6A). This
feature prompted us to ask whether the V2b complex recognizes
the V2-IN-specific Gata2-enhancer in vivo. To this end, we
performed chromatin immunoprecipitation (ChIP) analyses in
mouse embryonic P19 cells transfected with constructs ex-
pressing Gata2, SCL, and LMO4, which are expected to form
the V2b complex with endogenous NLI. Gata2-, SCL-, and
LMO4-containing chromatin-protein complexes were purified
by Gata2, SCL, and LMO4 antibodies, respectively, and
the presence of Gata2-enhancer in the chromatin-protein
complexes was determined by PCR. The ChIP assays revealed
that Gata2, SCL, and LMO4 are recruited to the genomic
Gata2-enhancer in cells (Figure 6C). Moreover, consistent with
the in vivo recruitment of the V2b complex, the Gata2-enhancer
linked to GFP reporter directs expression of GFP to Gata3+ V2b-
INs with ipsilateral axonal projections in chick embryos
(Figure 6D). We then asked whether ectopic expression of the
V2b complex activates Gata2 enhancer in the dorsal spinal
cord. Coinjection of SCL and LMO4, along with Gata2-enhan-
cer:GFP reporter, triggered GFP expression in the dorsal spinal
cord and dorsal root ganglion (Figures 6H and S5). Collectively,
these data suggest that the V2b complex regulates Gata2
expression during V2-IN development by binding to the Gata2-
enhancer.
The preceding observations indicate that repeated bipartite
DNA sequences consisting of E-boxes and GATA sites are likely
to be the signature motif recognized by the V2b complex in vivo.
Thus, we searched for similar motifs in Gata3 gene, a well-
established marker for V2b-INs. Our bioinformatics approach
discovered a 300 bp region in intron 3 of Gata3 gene, whose
sequences are highly conserved across multiple species
(Figure S6). Intriguingly, this intronic region includes an evolu-
tionarily conserved pair of bipartite E-box-GATA elements,
which is highly homologous to the Gata2-enhancer (Figure 6B).
ChIP experiments using P19 cells expressing Gata2, SCL and
LMO4 demonstrated that the V2b complex specifically binds
the genomic bipartite E-box-GATA elements of the Gata3 gene
(Figure 6C). To determine the functional responsiveness of this
300 bp intronic region of Gata3 gene to the endogenous V2b
complex, we asked whether this can direct reporter gene
expression to V2b-INs in the embryonic spinal cord. To this
end, we electroporated Gata3 genomic region linked to GFP
reporter to chick embryos and monitored GFP expression in
the neural tube. The strongest GFP expression was detected in
Gata3+ V2b-INs, but a small population of interneurons posi-
tioned medially along the dorsoventral axis also expressed
GFP (Figure 6F). These data establish that the 300 bp intronic
region of Gata3 gene functions as an enhancer to stimulate
transcription in V2b-INs by recruiting the V2b complex.
The presence of a pair of E-box-GATA composite elements in
Gata2/3-enhancers along with their in vivo recruitment of SCL,
Gata2, and LMO4 leads to the prediction that E-boxes and
GATA sites are required for the activity of Gata2/3-enhancers
in V2b-INs by serving as binding sites for SCL and Gata2 withinNeuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc. 845
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(A and B) E-box/E-box-like and GATA sites within Gata2-enhancer (A) or Gata3-enhancer (B) are underlined. Mutations in E-box/E-box-like or GATA sites are as
indicated.
(C) ChIP assays using P19 cells expressing Gata2, SCL, and LMO4.
(D–H) Immunohistochemical analyses in HH stage 24 chick embryos following electroporation of indicated constructs. GFP expression in the dorsal interneurons
is marked by brackets (F and G).the endogenous V2b complex. To test this, we mutated
either one or both of the E-box-GATA elements in Gata2/3-
enhancers and monitored their activity to drive gene transcrip-
tion in V2b-INs using chick embryo electroporations. For both
Gata2- and Gata3-enhancer:GFP reporters, mutation of each
pair of E-box-GATA unit resulted in weaker but significant GFP
expression in V2-INs (m1, m2, m4, and m5 in Figures 6A and
6B; data not shown). However, simultaneous mutation of both
E-box-GATA composite elements completely abolished GFP
expression in V2-INs by Gata2 and Gata3-enhancer:GFP
reporters (m3 and m6 in Figures 6A and 6B; Figures 6E and
6G), indicating that a pair of E-box-GATA composite elements
are needed for Gata2/3-enhancers to activate the gene tran-
scription in V2 cells. In contrast to V2-INs, GFP expression in
dorsal interneurons still persisted when the Gata3-enhancer
was mutated on both E-box-GATA elements (bracket in
Figure 6G), suggesting that expression in dorsal interneurons is
regulated independently of E-box-GATA composite elements.846 Neuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc.Collectively, we identified enhancers in Gata2 and Gata3
genes targeted by the V2b complex. Each enhancer contains
a pair of E-box and GATA composite elements and directs
gene expression to V2b-INs.
The V2b Complex Is Responsible for Transactivation
of the Gata2/3-Enhancers
To examine the requirement for the endogenous V2b complex in
stimulating Gata3-enhancer in V2b-INs, we assessed the tran-
scriptional activity of the Gata3-enhancer in the neural tube
upon disruption of the V2b complex assembly. To inhibit the
formation of the V2b complex, we utilized NLI-DD, which blocks
the self-association of NLI, and NLI-LID, which binds LIM
domains but lacks the dimerization domain (Figure S4; Thaler
et al., 2002). The Gata3-enhancer:GFP reporter was electropo-
rated into chick embryos along with vectors encoding LacZ
control, NLI-DD, or NLI-LID. Overexpressed NLI-DD or NLI-LID
suppressed the V2b-IN-specific enhancer activity of the
Neuron
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expression in the dorsal interneurons (Figure 7A). These results
suggest that the assembly of the V2b complex, mediated
by NLI through its ability to self-dimerize and to interact with
LIM-domains, is required for the Gata3-enhancer to stimulate
transcription in V2b-INs.
Next, we examined whether SCL and Gata2 synergize to
activate the Gata2/3-enhancers, physiological target elements
of the V2b complex, using luciferase reporter assays. SCL and
GATA2, alone or in combination, failed to strongly activate
the Gata2-enhancer:LUC or Gata3-enhancer:LUC reporters
(Figures 7B and 7C). Interestingly, the coexpression of LMO4,
NLI, and SSDP1 along with SCL and Gata2 resulted in a robust
stimulation of transcription in Gata2/3-enhancer:LUC reporters,
but not in Gata3-enhancer[m6]:LUC reporter in which a pair of
E-box-GATA composite elements are mutated (Figures 6B, 7B,
and 7C). These results suggest that formation of the V2b
complex and the subsequent recruitment of SSDP1 to E-box-
GATA composite elements are necessary to transactivate the
Gata2/3-enhancers effectively in cells.
It is possible that formation of the V2b complex facilitates
efficient binding of SCL and Gata2 to the combinatorial E-box-
GATA elements in Gata2/3-enhancers, and this enhancement
Figure 7. The Assembly of the V2b Complex
Is Required to Recognize and Transactivate
the Gata2/3 Enhancers
(A) GFP expression in chicks electroporated with
Gata3-enhancer:GFP along with LacZ, NLI-DD,
or NLI-LID. Brackets mark GFP expression in the
dorsal interneurons.
(B and C) Luciferase reporter assays with Gata2-
enhancer:LUC (B) and Gata3-enhancer:LUC (C)
in HEK293 cells.
(D) ChIP assays in P19 cells transfected with
Gata2, LMO4 and NLI along with HA-SCL or
HA-SCL-F238G (FG). The bottom panel shows
western blot analyses with HA-antibody.
(E) ChIP assays using spinal cord extracts from
E14.5 wild-type or LMO4 null embryos.
in DNA binding may underlie the tran-
scriptional synergy among components
of the V2b complex. To test this idea,
we transfected P19 cells with Gata2 and
LMO4 along with either HA-SCL or HA-
SCL-F238G mutant, which is defective
in forming the V2b complex in cells
(Figure 3F), and performed ChIP analyses
by immunopurifying the chromatin-
protein complex with HA-antibody.
Because SCL-F238G has an intact
DNA-binding basic domain and efficiently
heterodimerizes with E47, it is likely
capable of binding conventional E-boxes
as a SCL/E47 heterodimer. Interestingly,
although SCL-F238G was expressed no
less than SCL wild-type (Figure 7D),
SCL-F238G was not recruited to the
genomic Gata2/3-enhancers under the condition in which wild-
type SCL readily bound the Gata2/3-enhancers (Figure 7D).
These results support the idea that assembly of the V2b complex
promotes the efficient recruitment of SCL and Gata2 to the V2b
complex responsive enhancers.
LMO4 Is Required for the Efficient Binding of SCL
and Gata2 in the V2b Complex to Gata2/3 Enhancers
Given the essential role of LMO4 in nucleating the V2b complex
formation (Figure 3), we reasoned that inefficient assembly of the
V2b complex in LMO4 null embryos would compromise the
binding of SCL and Gata2 to the V2b complex response
elements thereby contributing to reduced Gata3 expression
and GABAergic neurons (Figure 2). To test this possibility, we
monitored the occupancy of the Gata2/3-enhancers by SCL
andGata2 in the spinal cord of wild-type and LMO4 null embryos
using ChIP assays. The spinal cords of E14.5 mouse embryos
were dissected and then SCL, Gata2, or NLI-containing chro-
matin-protein complexes were immunopurified by SCL, Gata2,
or NLI antibodies, respectively. The SCL, Gata2, and NLI
proteins in the spinal cord cells from wild-type embryos bound
the Gata2/3-enhancers (Figure 7E), in agreement with the
recruitment pattern in P19 cells (Figure 6C). This establishesNeuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc. 847
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LMO4 stimulates V2b-IN development bymediating the assembly of the V2b complex that recognizes E-box-GATA composite elements in V2b-IN genes, while it
inhibits differentiation of p2 progenitors to excitatory V2a-IN by suppressing the formation of Lhx3-containing V2-tetramer complex.that the endogenous V2b complex directly interacts with the
Gata2/3-enhancers. Interestingly, in contrast to wild-type
embryos, the recruitment of Gata2, NLI, and SCL to the Gata2/
3-enhancers was severely attenuated in LMO4 null spinal cords
(Figure 7E), indicating that LMO4 is needed for the efficient
binding of SCL, Gata2, and NLI to the Gata2/3-enhancers.
Because LMO4 lacks any DNA-binding domain, this function of
LMO4 is likely to reflect its role in promoting the assembly and
stabilization of the V2b complex. The greatly attenuated binding
of SCL and Gata2, two distinct DNA-binding components of the
V2b complex, to the Gata3-enhancer in LMO4-null embryos is
consistent with reduced expression of Gata3 (Figures 7E and
2A). Together, these results demonstrate that assembly of the
V2b complex mediated by LMO4 appears to be a prerequisite
for the efficient recognition of the Gata2/3-enhancers by SCL
and Gata2.
DISCUSSION
A majority of neurons in vertebrates make a developmental
choice between excitatory and inhibitory neurotransmitter
phenotypes, predominantly glutamatergic versus GABAergic
(Bennett and Balcar, 1999). As unbalanced activity of inhibitory
and excitatory neurons can result in various neuronal disorders,
the generation of neuronal subtypes with different neurotrans-
mitter phenotypes is tightly controlled during CNS development.
In this report, we identified LMO4 as a critical factor, which
controls this intricate balance during spinal V2-IN development
and refines the binary cell fate choices initiated by Notch-Delta
signaling. We further defined the biochemical basis of the dual
action of LMO4 in promoting GABAergic V2b fate and simulta-
neously inhibiting glutamatergic V2a fate.
Transcriptional Regulatory Pathway to Control
Excitatory and Inhibitory V2-IN Identities
In the ventral spinal cord, four classes of interneurons are further
subdivided into functionally distinct subtypes on the basis of
neurotransmitter choices, expression of marker genes, and848 Neuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc.axonal projections (Al-Mosawie et al., 2007; Lanuza et al.,
2004; Lundfald et al., 2007). Immature V2-INs expressing both
Lhx3 and Gata2 diversify into excitatory V2a-INs and inhibitory
V2b-INs over the same period of time (Figure 8; Peng et al.,
2007). Notch-Delta cell signaling orchestrates the initial diversifi-
cation step of V2-INs (Del Barrio et al., 2007; Kimura et al., 2008;
Peng et al., 2007). However, little is known about the transcrip-
tion regulators which control neurotransmitter identity in the
ventral spinal cord. We showed that LMO4 inhibits Lhx3 from
ectopically inducing the glutamatergic fate and cooperates
with SCL to suppress endogenous glutamatergic neuronal
differentiation and promote GABAergic neurotransmitter expres-
sion. Correspondingly, in LMO4/;SCL+/ compound mutant
embryos, the number of glutamatergic Chx10+ V2a-INs
increases dramatically at the expense of GABAergic Gata3+
V2b-INs, suggesting that prospective V2b-INs are converted to
V2a cells. Together, LMO4 promotes GABAergic neuron identity
and simultaneously suppresses glutamatergic neuron identity
during the diversification of V2-INs, keeping the necessary
balance between excitatory and inhibitory activities in the motor
circuit (Figure 8). This dual regulatory role for LMO4 involves its
positive role in assembling the V2b-IN-specifying V2b complex
with SCL and Gata2 as well as its negative action in disrupting
the assembly and activity of the V2a-IN-specifying 2NLI:2Lhx3
V2-tetramer complex (Figure 8; Lee et al., 2008). Our results
also raised the possibility that the LIM-complexes directing
V2a and V2b identities function as postmitotic selectors for
maintaining the desired neurotransmitter phenotypes.
The similarity in the process of choosing GABAergic over glu-
tamatergic neuronal cell fate between ventral and dorsal spinal
cord is noteworthy. In the dorsal spinal cord, another bHLH
factor Ptf1a (also known as p48) plays a central role in the gener-
ation of inhibitory GABAergic neurons while suppressing the
production of excitatory glutamatergic neurons (Glasgow et al.,
2005; Hori et al., 2008). Both Ptf1a and SCL form a multi-protein
complex to fulfill their function in neurotransmitter specification,
rather than functioning through a conventional heterodimer with
E-proteins. The formation of a complex between Ptf1a and Rbpj,
Neuron
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is required for Ptf1a to promote GABAergic neuronal identity
(Hori et al., 2008). Ptf1a/Rbpj-complex has been shown to
recognize DNA sequences consisting of Ptf1a-binding E-box
and Rbpj-binding T/C-box (Masui et al., 2007). Unlike Ptf1a,
Ptf1a-W298A mutant, which fails to cooperate with Rbpj in acti-
vating transcription, is inert in inducing GABAergic dILA neurons
and suppressing glutamatergic dILB neurons (Hori et al., 2008).
Similarly, the SCL-F238G mutant, defective in forming the V2b
complex, was unable to induce GABAergic V2b-INs and
suppress glutamatergic V2a-INs. Thus, it is tempting to
speculate that complex formation with multiple DNA-binding
components provides bHLH factors with higher specificity in
the recognition of target elements and subsequently target
gene selections. In support of this idea, we found that the
assembly of the V2b complex is required for the efficient binding
of SCL to the enhancers of V2b-IN genes Gata2/3. However, it is
unclear whether the V2b complex regulates genes involved in
GABAergic neurotransmission directly. Thus, it will be interesting
to test whether the V2b complex directly controls expression of
Gad1 gene in the ventral spinal cord through an evolutionarily
conserved E-box-GATA element that we have found in Gad1
gene (unpublished data). Different bHLH factors appear to be
required for GABAergic neurons in distinct regions of the nervous
system. For instance, Ptf1a and Mash1 mediate GABAergic
neuronal specification in dorsal spinal cord/cerebellum and
telencephalon/midbrain, respectively (Fode et al., 2000; Glas-
gow et al., 2005; Hoshino et al., 2005; Nakatani et al., 2007).
We report that SCL is important to establish GABAergic identity
of V2b-INs in the ventral spinal cord. Thus, genes involved in
GABAergic neurotransmission are likely to be regulated by
multiple bHLH factors in different regions of the vertebrate
CNS, rather than by universal regulators that govern all
GABAergic neuronal subtypes.
LMO4 Mediates the Assembly of the V2b Complex
In higher vertebrates, twelve LIM-HD and four LMO proteins
have been implicated in the development of multiple cell types
(Hobert and Westphal, 2000). The LIM-HD factors not only label
distinct cell populations within the nervous system (Tsuchida
et al., 1994) but also function in combinations by forming cell
type-specific complexes with a self-dimerizing adaptor NLI
protein (Thaler et al., 2002). Based on the fact that LMOs lack
a functional DNA-binding domain, they have been proposed to
disrupt the formation of conventional LIM-complexes consisting
of LIM-HD factors and NLI by competing with LIM-HD proteins
for NLI-interaction, thus acting as negative regulators of LIM-
complexes (Lee et al., 2008; Milan and Cohen, 1999; Milan
et al., 1998). In contrast, here we presented that LMO4 functions
as a positive transcriptional regulator by nucleating, along with
NLI, the assembly of a novel-type of LIM-complex comprised
of SCL and Gata2 during V2b-IN development. It is noteworthy
that a similar DNA-binding complex consisting of SCL, Gata1,
LMO2, and NLI has been proposed in hematopoietic cells (Wad-
man et al., 1997), although its exact stoichiometry remains
unknown. This indicates that formation of multiprotein
complexes bridged by LMOs may be a recurring strategy to
achieve cellular diversity in multiple tissues including the CNS.The one-to-one interaction profiles among SCL, Gata2, LMO4,
and NLI suggest at least four possible models for multiprotein
complexes. One possibility is that Gata2 forms a complex with
NLI, which then homodimerizes to form a 2Gata2:2NLI tetramer
(Figure S7A). Alternatively, SCL can interact with NLI via LMO4
and this complex then homodimerizes through NLI-dimerization
thereby forming a 2SCL:2LMO4:2NLI complex (Figure S7B).
Since these interactions are occurring in the same cell coex-
pressing SCL and Gata2, it is also possible that Gata2:NLI
associates with SCL:LMO4:NLI, forming a heteromeric Ga-
ta2:NLI-NLI:LMO4:SCL complex that may operate to coregulate
V2b-targets bySCL andGata2 (Figure S7C). However, a paradox
emerges in these complex assembly models. Considering that
all three complexes can be formed in a single cell that expresses
SCL, Gata2, LMO4, and NLI, only a fraction of the complexes will
have both SCL and Gata2. In a fourth model, an NLI:LMO4
module binds Gata2 and SCL simultaneously forming a subcom-
plex of Gata2:NLI:LMO4:SCL and NLI-dimerization subse-
quently results in the multiprotein complex that we denoted as
the V2b complex (Figures 3G and S7D). This model would ensure
an enrichment of both SCL and Gata2 in a single complex,
thereby avoiding the generation of multiple homomeric and
heteromeric complexes within a single cell. Our biochemical
analyses support this model, as incubation of multiple compo-
nents of the putative V2b complex tends to stabilize associations
among the subunits, rather than disrupting each interaction
(Figure 3). The composition of the V2b complex is also mirrored
in the cis-regulatory elements of the V2b-specific genes, Gata2
and Gata3, which consist of a pair of bipartite E-box-GATA
elements (Figures 6A and 6B). Our results do not exclude the
possibility that complexes which have either SCL or Gata2, but
not both, could still be instrumental in regulation of genes
responsive to SCL or Gata2 alone during V2b-IN differentiation.
For example, Gata2 expression precedes SCL expression in p2
progenitors differentiating to V2-INs, where it may regulate
a discrete set of genes by forming a complex with NLI, but not
with SCL.
The ‘‘LIM Code’’ in V2b-IN Specification
LIM-HD codes are crucial in implementing cell-type-specific
transcription by directing different types of LIM-complexes in a
cell context-dependent manner (Thaler et al., 2002). Our studies
expand the LIM codes to include bHLH and Gata proteins as
these two factors form an atypical LIM-complex via a non-DNA
binding LIM factor LMO4. Unlike typical LIM-complexes such
as the V2-tetramer complex, which utilize LIM-HD proteins for
recognition of specific DNA response elements (Figure 8; Lee
et al., 2008), SCL and Gata2 serve as the major DNA-binding
components in the V2b complex. A couple of unique advantages
of assembling the V2b complex can be proposed in cell fate
specification.
First, our results suggest that the V2b complex allows integra-
tion of SCL and Gata2 functions by selecting a group of target
genes that bear both SCL- and GATA-recognition sites. This
should ensure the expression of V2b-target genes specifically
in cells coexpressing SCL and Gata2. We found that the
enhancers of Gata2 and Gata3 genes display striking similarity
in that they contain reiterated bipartite elements composed ofNeuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc. 849
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ing and GATA sites for recruiting Gata proteins. E-boxes and
GATA sites occur relatively often in the genome due to their short
sequences and serve as binding motifs for multiple bHLH and
Gata factors. Thus, simultaneous recognition of paired E-box-
GATA composite elements by the V2b complex is expected to
provide the required stringency in choosing the target genes
coregulated by SCL and Gata2.
Second, we found that formation of the V2b complex facili-
tates the transcriptional synergy among its components by
enabling the recruitment of coactivators including SSDP1. Coex-
pression of SSDP1 allowed a potent transcriptional activation
by the V2b complex on its physiological targets, Gata2/3-
enhancers. Given that SCL and Gata2 are relatively weak tran-
scriptional activators in Gal4-DBD fusion transcription assays,
the transcriptional synergy between SCL and Gata2 resulting
from forming a complex may be due, at least in part, to the
recruitment of SSDP1. The facilitated recruitment of SSDP1
and possibly other coactivators may account for the necessity
of the V2b complex formation for inducing the V2b-IN genes.
EXPERIMENTAL PROCEDURES
Mice
The SCL and LMO4 mutant mice have been previously described
(Elefanty et al., 1998; Lee et al., 2005a). Embryos were collected at stages
E11.5–E15.5, fixed in 4% paraformaldehyde, sunk in 30% sucrose embedded
in OCT for cryosectioning and subsequent analyses.
In Ovo Electroporation, Immunohistochemistry,
and In Situ Hybridization
In ovo electroporation was performed as described (Thaler et al., 2002). Briefly,
plasmid DNA was injected into the lumen of the neural tube of HH stage
13 chick embryos which were then electroporated. A mammalian expression
vector expressing DsRed or GFP (Clontech) or nuclear lacZ was co-injected
to monitor electroporation efficiency. The embryos were harvested at HH
stage 24-26, fixed in 4% paraformaldehyde, embedded in OCT and cryosec-
tioned at 12–18 mm. Immunohistochemistry and in situ hybridization were
performed as described (Thaler et al., 2002). Digoxigenin-labeled riboprobe
complementary to mouse or chick Vglut2 and Gad1; mouse Gata2, SCL,
and LMO4 were used for in situ hybridization.
Quantification and Statistical Analysis
Cell countswere obtained from 12 mmsections of embryos and represented as
a ratio to cells in the control side in chicks and a ratio to cells in the wild-type
littermate in mice with standard deviation as error bars. The significance was
determined using two-tailed Student’s t test.
Cell Culture and Luciferase Assays
Cell culture and luciferase assays were used as described (Lee et al., 2005b).
Histograms show mean normalized luciferase units and error bars represent
standard deviation. All transfections were repeated multiple times.
CoIP, ChIP, GST Pull-Down, and Yeast Two-Hybrid Assays
These assays were performed as described previously (Lee et al., 2005b,
2008). In yeast two hybrid assays, at least eight independently derived colo-
nies were tested for each protein interaction experiment.
Quantitative Reverse Transcriptase PCR (qRT-PCR)
Total RNA was isolated from mouse embryonic spinal cord tissue using
BioRad mini-kit. Superscript II (Invitrogen) was used for reverse transcription.
qRT-PCR was performed using SYBR-Green kit (Invitrogen) and Mx3000P
(Stratagene). Three different litters have been analyzed and the representative850 Neuron 61, 839–851, March 26, 2009 ª2009 Elsevier Inc.results are shown. The primers used were as follows: mouse Gata3, forward
50-CTT ATC AAG CCC AAG CGA AG, reverse 50-TTT GCA CTT TTT CGA
TTT GC; Cyclophilin, forward 50-GTC TCC TTC GAG CTG TTT GC, reverse
50-GAT GCC AGG ACC TGT ATG CT.
Additional experimental procedures are provided as supplements.
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The Supplemental Data include seven figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.neuron.org/
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